The alliance is comprised of a growing network of leading cancer centers from across the country that demonstrate a commitment to precision medicine and work collaboratively to:
- Integrate molecular testing where appropriate into cancer care and patient treatment management
- Collaborate on research studies and clinical trials
- Track longitudinal clinical outcomes, contribute data, and correlate outcomes with molecular clinical demographic attributes
- Publish innovative abstracts and manuscripts in top-tier journals promoting academic advancement in molecular profiling and its impact on clinical care
It’s important for oncologists and patients to know that their data is available to them for analysis. Our database of clinical outcomes is populated with anonymized data from POA member institutions and from commercially available data. This continuous feedback loop between finding new biomarkers and interpreting their significance, provides insights for drug developers and aids in the promotion of clinical trials, which ultimately feeds back into our system and directly helps patients. This cultivation of combined clinical-genomic data and collaborative research helps the POA and all of its members advance the science of cancer care.